Genomic Main Phase - Early Diagnosis

Lead Participant: AMGEN LIMITED

Abstract

Awaiting Public Project Summary

Lead Participant

Project Cost

Grant Offer

AMGEN LIMITED £12,500,000 £ 12,500,000
 

Participant

INNOVATE UK

Publications

10 25 50